Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Completed · Not applicable

Conditions studied: Ovarian Cancer, Fallopian Tube, Primary Peritoneal

In brief

The purpose of this study is to see if Positron Emission Tomography (PET) probes make it easier for your surgeon to find cancer and remove it during your surgery. A PET probe is a wandlike device that can detect radioactivity.

Key facts

Study ID: NCT01826227
Run by: Memorial Sloan Kettering Cancer Center
People needed: 5
Starts: 2013-03-01
Expected to finish: 2016-12-01
Last updated by the study team: 2017-11-06

Who can join

Age: 19 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

Pathologically proven diagnosis of ovarian carcinoma, fallopian tube, or primary peritoneal not to include tumors of low malignant potential (all stage, grade, and histology)
First recurrence
Platinum sensitive as defined by disease free interval ≥ 6 months
Radiological evidence of recurrent disease on preoperative PET/diagnostic CT
Planned surgical secondary cytoreduction via laparotomy
>18 years old

You may not qualify if…

Secondary cytoreduction via laparoscopy or robotically assisted laparoscopy
Tumors of low malignant potential
Beyond first recurrence
With the exception of non-melanoma skin cancer, subjects with other invasive malignancies, who had (or have) any evidence of the other cancer present within the last 5 years, are excluded
Active infection requiring parenteral antibiotics
For subjects with diabetes mellitus, a blood sugar will be checked preoperatively and must be <200 for participation in the study

Where it is running

Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.